MedisourceRx

Los Alamitos, United States Founded: 2019 • Age: 7 yrs Acquired By Hims
Sterile medications are produced for hospitals and surgery centers.

About MedisourceRx

MedisourceRx is a Healthcare company based in Los Alamitos (United States) founded in 2019, and was acquired by Hims in September 2024. Sterile medications are produced for hospitals and surgery centers. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include QuVa Pharma, Exela Pharma and Summit Biosciences; 2 of its 3 listed competitors have raised funding.

Company details

MedisourceRx was founded in 2019 as a 503B outsourcing facility in Los Alamitos, United States, within the pharmaceutical sector. Customized sterile medications are manufactured for hospitals, surgery centers, and clinical trials. Operations follow cGMP procedures and USP standards to maintain product potency, sterility, and freedom from endotoxins. Dedicated staff supports trial needs, and accessible solutions are provided to healthcare providers.

  • Headquarters Los Alamitos, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website medisourcerx.com
  • Social LinkedIn
  • Acquired by Hims (Sep 2024)
Key Metrics

Investors in MedisourceRx

MedisourceRx has secured backing from 1 investor. Prominent investors backing the company include Hims.

All
InvestorDescriptionFounded YearDomainLocation
Online platform offering telehealth services for men's wellness
2017hims.comSan Francisco, United States
Premium access

Investor details for MedisourceRx

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MedisourceRx

2 dated milestones of MedisourceRx across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded MedisourceRx is founded.
  2. Exit Acquired by Hims.

Competitors of MedisourceRx

MedisourceRx has 3 listed competitors in our database, 2 of them funded. They include QuVa Pharma, Exela Pharma and Summit Biosciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
quvapharma.com2015Sugar Land, United States$15M
Sterile compounding pharmacy services
exelapharma.com2005Lenoir, United States$7.09M247
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
summitbiosciences.com2008Lexington, United States
Nasal spray drug products are developed, manufactured, and commercialized.
Premium access

Detailed competitors of MedisourceRx

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as MedisourceRx (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medisourcerx

Premium access

Complete news archive for MedisourceRx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MedisourceRx

MedisourceRx was founded in 2019.

MedisourceRx is headquartered in Los Alamitos, United States. It is registered at Los Alamitos, California, United States.

MedisourceRx was founded in 2019 as a 503B outsourcing facility in Los Alamitos, United States, within the pharmaceutical sector. Customized sterile medications are manufactured for hospitals, surgery centers, and clinical trials. Operations follow cGMP procedures and USP standards to maintain product potency, sterility, and freedom from endotoxins. Dedicated staff supports trial needs, and accessible solutions are provided to healthcare providers.

MedisourceRx's top competitors include Exela Pharma, QuVa Pharma and Summit Biosciences.

MedisourceRx has 1 investor. Key investors include Hims.

Yes. MedisourceRx was acquired by Hims in September 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available